Search Results - "Greenberg, Richard N"
-
1
Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
Published in Journal of hepatology (01-05-2019)“…[Display omitted] •Efavirenz is widely prescribed for patients with HIV.•Efavirenz increases the risk of dyslipidemia and hepatic steatosis in…”
Get full text
Journal Article -
2
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
Published in The Lancet infectious diseases (01-03-2013)“…Summary Background Replication-competent virus vector vaccines might have advantages compared with non-replicating vector vaccines. We tested the safety and…”
Get full text
Journal Article -
3
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
Published in PloS one (06-10-2015)“…Replicating smallpox vaccines can cause severe complications in individuals with atopic dermatitis (AD). Prior studies evaluating Modified Vaccinia Ankara…”
Get full text
Journal Article -
4
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
Published in PloS one (21-06-2016)“…Modified Vaccinia Ankara MVA-BN® is a live, highly attenuated, viral vaccine under advanced development as a non-replicating smallpox vaccine. In this Phase II…”
Get full text
Journal Article -
5
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
Published in Human vaccines & immunotherapeutics (31-12-2024)“…Modified Vaccinia Ankara Bavarian Nordic (MVA-BN) as a smallpox and mpox vaccine has been approved in its liquid-frozen (LF) formulation in the US, Canada, and…”
Get full text
Journal Article -
6
Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections
Published in Clinical infectious diseases (01-05-2003)“…Treatments for invasive fungal infections remain unsatisfactory. We evaluated the efficacy, tolerability, and safety of voriconazole as salvage treatment for…”
Get full text
Journal Article -
7
Safety and Immunogenicity of Single-Dose Live Oral Cholera Vaccine Strain CVD 103-HgR, Prepared from New Master and Working Cell Banks
Published in Clinical and Vaccine Immunology (01-01-2014)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
8
The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High-Dose Vancomycin Combined with Saccharomyces boulardii
Published in Clinical infectious diseases (01-10-2000)“…Recurrent Clostridium difficile disease (CDD) is a difficult clinical problem because antibiotic therapy often does not prevent further recurrences. In a…”
Get full text
Journal Article -
9
Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections
Published in Clinical infectious diseases (15-06-2006)“…Background. Invasive fungal infections are found most frequently in immunosuppressed and critically ill hospitalized patients. Antifungal therapy is often…”
Get full text
Journal Article -
10
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
Published in Human vaccines & immunotherapeutics (04-03-2019)“…Vaccination with the 13-valent pneumococcal conjugate vaccine (PCV13) followed ≥ 1 year by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) is…”
Get full text
Journal Article -
11
Caregiving, repetitive thought, and immune response to vaccination in older adults
Published in Brain, behavior, and immunity (01-07-2008)“…Abstract Chronic stressors such as caregiving have been associated with reduced antibody production after vaccination and elevated interleukin (IL)-6 in older…”
Get full text
Journal Article -
12
Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients
Published in Journal of the International Association of Providers of AIDS Care (01-09-2017)“…The duration of macrocytosis after stopping zidovudine (ZDV) is unknown. Among 104 HIV-infected patients treated with ZDV for more than 1 year, 84 patients had…”
Get full text
Journal Article -
13
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel
Published in Clinical infectious diseases (17-05-2018)“…Blood cultures are approximately 50% sensitive for diagnosing invasive candidiasis. The T2Candida nanodiagnostic panel uses T2 magnetic resonance and a…”
Get full text
Journal Article -
14
Levofloxacin efficacy in the treatment of community-acquired legionellosis
Published in Chest (01-06-2004)“…Although fluoroquinolones possess excellent in vitro activity against Legionella, few large-scale clinical trials have examined their efficacy in the treatment…”
Get more information
Journal Article -
15
A Paradigm Shift Has Begun: Diarrheal Disease Takes a New Form
Published in Clinical infectious diseases (15-10-2019)Get full text
Journal Article -
16
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age
Published in Vaccine (25-04-2014)“…Highlights • Conjugate pneumococcal polysaccharide vaccine allows for recall immune response. • This recall response occurs after follow-on use of conjugate or…”
Get full text
Journal Article -
17
-
18
Temporal Trends, Clinical Characteristics, and Outcomes of Histoplasmosis in a Tertiary Care Center in Kentucky, 2000 to 2009
Published in Journal of the International Association of Providers of AIDS Care (01-03-2014)“…The impact of highly active antiretroviral therapy (HAART) on the epidemiology of AIDS-associated histoplasmosis in the past decade is poorly defined. Among…”
Get full text
Journal Article -
19
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Published in Vaccine (02-08-2013)“…Highlights • Free polysaccharide pneumococcal vaccine is generally recommended for older adults. • Conjugate and free polysaccharide vaccines were compared in…”
Get full text
Journal Article -
20
IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine
Published in Expert review of vaccines (01-01-2009)“…Smallpox vaccines based on replicating vaccinia virus are known to elicit rare yet serious adverse events, particularly in human populations with immune…”
Get more information
Journal Article